ENPP2 and obesity disorder: The autotaxin/LPA pathway mediates diverse biological actions including activation of preadipocyte proliferation [38], suppression of brown adipose differentiation [39], and promotion of systematic inflammation [40] which lead to increased risk for cardiometabolic diseases including obesity and insulin resistance [41–42].